Status:
RECRUITING
Database for the Assessment of Efficacy and Safety of BPH Treatment
Lead Sponsor:
Dominik Abt
Conditions:
Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia
Eligibility:
MALE
18+ years
Brief Summary
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperpla...
Detailed Description
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperpla...
Eligibility Criteria
Inclusion Criteria:
- All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
- Patient age ≥ 18 years
- Informed consent provided
Exclusion Criteria:
-Cognitive impairment not allowing Informed Consent or adequate data assessment.
Key Trial Info
Start Date :
July 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03521648
Start Date
July 7 2017
End Date
December 1 2027
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Gallen Cantonal Hospital
Sankt Gallen, Canton of St. Gallen, Switzerland, 9007